In the largest and most conclusive study of its kind, researchers have analysed blood samples to create a novel and non-invasive way of helping to diagnose Alzheimer’s disease and distinguish between different types of neurodegenerative disorders.
Following this breakthrough discovery, Alzheimer’s sufferers may now have an additional test to improve the accuracy of diagnosis in order to better tailor appropriate treatment.
The research also offers a valuable opportunity to monitor the progression of the disease.
The international study in the Proceedings of the National Academy of Sciences USA used sensor-based technology with a diamond core to analyse approximately 550 blood samples.
By passing light through the diamond and observing its interactions with the blood plasma, researchers were able to identify specific chemical bonds within the blood. This biochemical data was used to compare blood samples from cases of Alzheimer’s disease and other neurodegenerative diseases with those from healthy controls.
The ground-breaking scientific investigation was carried out by researchers at Lancaster University, the University of Central Lancashire (UCLan), the University of Manchester and the Federal University of Rio Grande do Norte, Brazil.
Professor David Allsop from Lancaster University has been collaborating for many years withProfessor David Mann from the University of Manchester in searching for diagnostic markers for neurodegenerative disease in blood plasma.
They provided all of the plasma samples for the study, along with supporting clinical and genetic information, and expertise in Alzheimer’s and other neurodegenerative conditions.
Professor Allsop said: “A particularly exciting aspect of the study was the ability to distinguish accurately between Alzheimer’s disease and Lewy body dementia, which are conditions that both result in dementia and can be difficult to separate from each other based on clinical information and symptoms. By reduction of misdiagnosed cases and administration of appropriate treatment, many people could benefit from this type of blood test in the future.”
Alzheimer’s diagnosis currently involves careful medical evaluation including clinical history, memory testing and brain scans, yet the only conclusive diagnosis is determined by post-mortem examination. This new blood test offers a non-invasive, more accurate and relatively cost-effective method of diagnosis, which will ensure the correct management of the condition.
Professor Francis Martin, principal investigator of the study and Biosciences theme lead at UCLan, said: “We have an aging population, meaning that the incidence and prevalence of Alzheimer’s is increasing, as is the need for accurate diagnosis. The ability to identify different neurodegenerative diseases through the analysis of blood offers a faster and accurate way of establishing the most effective treatment plan as well as disease monitoring.”
This new approach could also offer potential for carrying out tests to identify and monitor early signs of mild cognitive impairment, meaning that the onset of Alzheimer’s and other types of neurodegenerative diseases could be detected early and intervention measures could be put in place earlier to slow the progress of these diseases.
Professor Martin added: “For those suffering with Alzheimer’s disease, the damage is already well advanced once conventionally diagnosed, but this new method offers a potentially effective early screening tool when patients are only demonstrating signs of mild cognitive impairment. This is a potentially significant breakthrough for the prevention of different debilitating and chronic neurological diseases.”
The Latest on: Alzheimer’s
- Graeme 'Changa' Langlands dies at 76 on January 20, 2018 at 4:23 pm
In recent months Langlands had battled dementia and alzheimers and was unable face court on charges of indecent dealing with a girl under 16 over allegations stemming back to the 1980s. Very sad to hear of the passing of the great Graeme Langlands. […]
- Rugby league immortal Graeme Langlands dead on January 20, 2018 at 4:03 pm
"His family are relieved by the nurse's advice that his passing was peaceful and painless." The 76-year-old had been suffering from dementia and alzheimers according to his lawyer, amid allegations of indecent treatment of a girl under 16 in the 1980s. […]
- Rugby League Immortal Graeme Langlands dies after long period of ill health on January 20, 2018 at 3:15 pm
He was 76-years-old. Lawyers acting for Langlands recently told a Brisbane court he was suffering from dementia and alzheimers and could not defend an allegation from the 1980s. Detectives in New South Wales charged Langlands with six counts of indecent ... […]
- Longevity and Diet on January 20, 2018 at 5:53 am
A dysregulation of these mitochondrial dynamics and abnormal morphology (shape) of these mitochondrion are hallmarks of aging and thought to contribute to many degenerative diseases such as Alzheimers and Parkinsons. With age, many studies report increased ... […]
- Roe v. Wade: One woman's journey to pro-life on January 19, 2018 at 5:43 pm
For instance people with severe IDD, Alzheimers, mental illness and so on — is it OK to kill them and take a life? Pro-abortion people will often say it is a woman’s reproductive choice and right and up to her and her doctor to decide. For me ... […]
- Heartbreaking moment woman breaks down talking about Alzheimers on January 17, 2018 at 10:48 am
This is the heartbreaking moment that a woman broke down in tears after talking about her children having a 50% chance of getting Alzheimers. […]
- The ‘king of romance’ finds comfort in Catholic faith and prayer as wife battles Alzheimers on January 17, 2018 at 7:39 am
There’s no sitting still for Englebert Humperdinck. At 81, the “king of romance” still performs several concert dates a year and in late 2017, he released his latest album, “The Man I Want to Be.” He will return to the Coast for two shows at the ... […]
- Global Alzheimers Disease Drug Market Comprehensive Analysis, Growth & Forecast by 2025 on January 17, 2018 at 12:48 am
(EMAILWIRE.COM, January 17, 2018 ) A fresh report has been added to the wide database of Market Research Hub (MRH) titled “Global Alzheimers Disease Drug Market Research Report 2018” which provides an outlook for current market value as well as the ... […]
- Workshop for signs of Alzheimers set for Tuesday in Dunkirk on January 6, 2018 at 9:06 pm
BUFFALO — Every 66 seconds across the United States, someone develops Alzheimer’s disease. Early diagnosis is critical to ensure that families can plan for the future together, take advantage of available resources and take part in social engagement ... […]
via Google News and Bing News